期刊文献+

隐匿性乙型肝炎病毒感染患者S基因突变特点分析 被引量:14

Characteristics of S gene mutation in patients with occult HBV infection
下载PDF
导出
摘要 目的分析1例血清HBV DNA长期阳性但HBsAg阴性的隐匿性乙型肝类病毒感染(OBI)患者HBV S基因突变特点,揭示S基因突变与OBI发生及肝脏疾病进展的关系。方法收集该患者不同时间点的4份血清样本,扩增HBV S基因并进行克隆测序,挑选代表性突变株病毒基因构建重组载体并进行表型分析。结果从该患者4份血清样本中检出多种S基因突变形式,包括前S1区大片段缺失、s126–127"RPCMNCTI"插入突变、sQ129N、s131–133 TSM→NST和经典的sG145R突变等,其中s131–133 TSM→NST在前后4份动态样本的检测病毒克隆中所占比例分别为0%、26%、59%和74%;前S1区大片段缺失在4份样本检测病毒克隆中始终存在,所占比例分别为26%、17%、15%和21%。表型分析发现,sQ129N和s131–133 TSM→NST可以降低抗体对HBsAg的亲和力,增加病毒分泌;与野生株相比,前S1区大片段(nt 3046–3177)缺失病毒株复制力下降了43.7%,表面抗原启动子Ⅱ(SPⅡ)活性下降了97.2%;sG145R可降低病毒的分泌能力。结论此例HBV感染患者的长期OBI临床表现是由于其感染有多种S基因突变病毒株引起,其中一些S基因突变可以影响病毒的表型特点,可能与肝脏疾病进展密切相关。 Objective To analyze characteristics of HBV S gene mutation in one patient with occult hepatitis B virus infection, who was positive for serum HBV DNA for long term, but negative for HBsAg in order to reveal the correlation between S gene mutation and development of OBI as well as the progression of the liver disease. Methods Four serum samples were collected at different time-points for the use of amplifying HBV S gene and performing cloning-sequencing. The representative S mutants were selected to construct recombinant vectors for phenotype analysis. Results Several S-gene mutational patterns were detected in the samples, including pre-S1 large fragment deletion, s126-127 "RPCMNCTI" insertion, sQ129N, s131-133 TSM--~NST, and classical sG14SR mutations. In sequential 4 samples, s131-133 TSM→NST mutation was detected in 0%, 26%, 59% and 74% of viral clones, respectively. The pre-S1 large fragment deletion was constantly found in the 4 serum samples, accounting for 26%, 17%, 15% and 21% of detected viral clones, respectively. Phenotypic analysis showed that sQ.129N and s131-133 TSM → NST mutations reduced the affinity of the antibody to HBsAg and increased the secretion of virus particles. Compared with the wild-type strainj the replication capacity and surface antigen promoter Ⅱ (SP Ⅱ ) activity of large fragment-deleted (nt 3046-3177 deletion) strain were decreased by 43.7% and 97.2%, respectively. In addition, sG14SR-induced impairment to secretion capacity of viral particles was verified. Conclusions Clinical presentations of long-term OBI of this HBV-infected patient could he caused by multiple S-gene mutants.Some S-gene mutations influence viral phenotypic characteristics, which might closely be related to the progression of liver disease.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2015年第3期178-183,共6页 Medical Journal of Chinese People's Liberation Army
基金 国家自然科学基金(81373136 81271847)~~
关键词 肝炎病毒 乙型 突变 肝炎表面抗原 乙型 hepatitis B virus mutation HBsAg
  • 相关文献

参考文献23

二级参考文献36

  • 1高学松,成军,甄真,郭江,张黎颖.乙型肝炎核心启动子的研究进展[J].世界华人消化杂志,2005,13(8):933-936. 被引量:5
  • 2Zoulim F. Are novel combination therapies needed for chronic hepatitis B[J]. ? Antiviral Res, 2012, 96(2): 256-259.
  • 3Segovia MC, Chacra W, Gordon SC. Adefovir dipivoxil in chronic hepatitis B: history and current uses[J]. Expert Opin Pharmacother, 2012, 13(2): 245-254.
  • 4Liu Y, Zhong Y, Zou Z, et al. Features and clinical implications of Hepatitis B virus genotypes and mutation in basal core promoter/precore region in 507 Chinese patients with acute and chronic hepatitis B[J].J Clin Virol, 2010, 47(3): 243-247.
  • 5Kim JW, Lee HS, Woo GH, et al. Fatal submassive hepatic necrosis associated with tyrosine-methionine- aspartate- aspartate-motif mutation of hepatitis B virus after long-term lamivudine therapy[J]. Clin Infect Dis, 2001, 33(3): 403-405.
  • 6Peters MG, Harm HW, Martin P, et al. Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine- resistant chronic hepatitis B [J]. Gastroenterology, 2004, 126(1): 91-101.
  • 7Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, et al. Long- term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years [J]. Gastroenterology, 2006, 131(6): 1743-1751.
  • 8Chen CH, Wang JH, Lu SN, et al. Characteristics of adefovir resistance in patients with or without lamivudine-resistant hepatitis B virus treated with adefovir: a 4-year experience[J]. Liver Int, 2011, 31(2): 206-214.
  • 9Lok AS, Zoulim F, Locarnini S, et al. Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management [J]. Hepatology, 2007, 46 ( 1): 254-265.
  • 10Ji D, Liu Y, Li L, et al. The rtL229 substitutions in the reverse transcriptase region of hepatitis B virus (HBV) polymerase are potentially associated with lamivudine resistance as a compensatory mutation[J]. J Clin Virol, 2012, 54(1): 66-72.

共引文献45

同被引文献87

  • 1余文辉,张春雷,冯玉丽,周大桥,贺劲松,周小梅,李伟雄,陈雪红,林卓玲,邓剑玲.乙型肝炎病毒基因分型与前C基因和基本核心启动子突变分析[J].中华临床医师杂志(电子版),2011,5(12):3464-3468. 被引量:5
  • 2张汉荣,孙梅,刘新钰,赵巍,曹利,李敏.抗-HBe阳性乙型肝炎病毒C基因启动子和前C基因变异[J].临床肝胆病杂志,2005,21(1):14-16. 被引量:4
  • 3侯金林,梁炽森,骆抗先.乙型肝炎病毒S基因“a”决定簇基因序列的多态性[J].中华微生物学和免疫学杂志,1996,16(1):1-4. 被引量:9
  • 4Ding F, Yu HG, Li YX, et al. Sequence analysis of the HBV S protein in Chinese patients with coexisting FIBsAg and anti- HBs[J].J Med Virol, 2015, 87(12): 2067 -2073.
  • 5Lada O, Benhamou Y, Poynard T, et al. Coexistence of hepatitis B surface antigen (HBsAg) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of "a" determinant variants[J]. J Virol, 2006, 80(6): 2968-2975.
  • 6Yu DM, Li XH, Morn V, et al. N-glycosylation mutations within hepatitis B virus surface major hydrophilic region contribute mostly to immune escape[J]. J Hepatol, 2014, 60(3): 515-522.
  • 7Ji D, Liu Y, Si LL, et al. Variable influence of mutational patterns in reverse-transcriptase domain on replication capacity of hepatitis B virus isolates from antiviral-experienced patientsJ. Clin Chim Acta, 2011,412(3-4): 305-313.
  • 8Kajiwara E, Tanaka Y, Ohashi T, et al. Hepatitis B caused by a hepatitis B surface antigen escape mutant[J]. J Gastroenterol, 2008, 43(3): 243-247.
  • 9Liu W, Hu T, Wang X, et al. Coexistence of hepatitis B surface antigen and anti-FIBs in Chinese chronic hepatitis B virus patients relating to genotype C and mutations in the S and P gene reverse transcriptase region[J]. Arch Virol, 2012, 157(4): 627-634.
  • 10Wang L, Liu H, Ning X, et al. Sequence analysis of the S gene region in HBV DNA from patients positive for both HBsAg and HBsAb tests[J]. Hepatol Res, 2010, 40(12): 1212-1218.

引证文献14

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部